SuperworthMedline revenue MDLN
Sales by quarter and over the last twelve months, from 2025.
- Last 12 months, to Jun 27, 2026
- n/m
- a quarter missing
- Latest quarter, Q2 FY26
- $7.7B
- +12% on a year earlier
Medline's twelve-month revenue can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q2 FY26, it was $7.7B, up 12% on the same quarter a year before.
Revenue over time
Quarter by quarter
| Quarter | Ended | Revenue | On a year earlier |
|---|---|---|---|
| Q2 FY26 | $7.7B | +12% | |
| Q1 FY26 | $7.4B | +11% | |
| Q2 FY25 | $6.9B | n/a | |
| Q1 FY25 | $6.6B | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Medline's size, closest first, today.
| Company | Revenue, 12 months | Growth |
|---|---|---|
| MDLNMedline | n/m | |
| BDXBecton, Dickinson and | $20.8B | +5% a year |
| RMDResMed | $5.7B | +10% a year |
| WSTWest Pharmaceutical Services | $3.3B | +12% a year |
| SOLVSolventum | $8.3B | −1% a year |
| PENPenumbra | $1.5B | +18% a year |
| ISRGIntuitive Surgical | $11.6B | +20% a year |
| COOCooper Companies | $4.2B | +5% a year |
| ALGNAlign Technology | $4.1B | +4% a year |
| GMEDGlobus Medical | $3.1B | +20% a year |
| PODDInsulet | $3.1B | +29% a year |
| Peer median | $4.2B |
What the revenue tells you
Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.
Growing revenue with shrinking margins is a warning, not a win.
More on Medline
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.